Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-96,165
Closed -$2.69M 1001
2016
Q4
$2.69M Sell
96,165
-232,291
-71% -$6.51M 0.02% 585
2016
Q3
$9.01M Buy
328,456
+148,941
+83% +$4.09M 0.06% 304
2016
Q2
$3.92M Buy
179,515
+118,208
+193% +$2.58M 0.03% 445
2016
Q1
$1.37M Buy
61,307
+52,307
+581% +$1.17M 0.01% 640
2015
Q4
$249K Buy
+9,000
New +$249K ﹤0.01% 894
2015
Q3
Sell
-100,137
Closed -$2.48M 1248
2015
Q2
$2.48M Buy
+100,137
New +$2.48M 0.03% 425

Other funds holding QGENF

Marshall Wace's QGENF Position: Q1 2017 in Review

Marshall Wace sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 96,165 shares — an estimated $2.69M sold.

Marshall Wace first reported a position in QGENF in Q2 2015 and held it in 6 quarters. The position peaked at $9.01M in Q3 2016. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Marshall Wace reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Marshall Wace sold 96,165 QIAGEN NV shares in Q1 2017, an estimated $2.69M.
  • Marshall Wace first reported a position in QIAGEN NV in Q2 2015 and held it in 6 quarters.
  • Marshall Wace's QIAGEN NV position peaked at $9.01M in Q3 2016.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Marshall Wace's 13F filing for Q1 2017, filed 12 May 2017.